Tom R DeMeester
Overview
Explore the profile of Tom R DeMeester including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
109
Citations
2556
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
DeMeester T
Dis Esophagus
. 2023 Jun;
36(Supplement_1).
PMID: 37317933
The common denominator for virtually all episodes of gastroesophageal reflux in health and disease is the loss of the barrier that confines the distal esophagus to the stomach. Factors important...
2.
Siboni S, Bonavina L, Rogers B, Egan C, Savarino E, Gyawali C, et al.
J Clin Gastroenterol
. 2022 Sep;
56(10):821-830.
PMID: 36084164
With the advent of high-resolution esophageal manometry, it is recognized that the antireflux barrier receives a contribution from both the lower esophageal sphincter (intrinsic sphincter) and the muscle of the...
3.
Holscher A, DeMeester T, Schmidt H, Berlth F, Bollschweiler E
Langenbecks Arch Surg
. 2020 May;
405(4):521-532.
PMID: 32388717
Background: This study compared the outcome between patients who had an open and those who had a hybrid esophagectomy for T1 or T3 esophageal adenocarcinoma (eAC). No clear data are...
4.
Ayazi S, DeMeester S, Hagen J, Zehetner J, Bremner R, Lipham J, et al.
J Am Coll Surg
. 2019 Apr;
229(2):210-216.
PMID: 30998974
Background: Attention has been focused on the amplitude of esophageal body contraction to avoid persistent dysphagia after a Nissen fundoplication. The current recommended level is a contraction amplitude in the...
5.
Labenz J, Chandrasoma P, Knapp L, DeMeester T
World J Gastrointest Endosc
. 2018 Oct;
10(9):175-183.
PMID: 30283600
The progression of gastroesophageal reflux disease (GERD) in patients who are taking proton pump inhibitors (PPIs) has been reported by several investigators, leading to concerns that PPI therapy does not...
6.
DeMeester T
Gastroenterol Hepatol (N Y)
. 2017 Apr;
13(2):128-129.
PMID: 28450820
No abstract available.
7.
Greene C, Worrell S, Attwood S, Chandrasoma P, Chang K, DeMeester T, et al.
J Gastrointest Surg
. 2015 Dec;
20(4):851-60.
PMID: 26691147
Introduction: Endoscopic therapy has revolutionized the treatment of Barrett's esophagus with high-grade dysplasia (HGD) or intramucosal adenocarcinoma by allowing preservation of the esophagus in many patients who would previously have...
8.
DeMeester T, Smith C
J Laparoendosc Adv Surg Tech A
. 2015 Sep;
25(9):695-701.
PMID: 26375770
No abstract available.
9.
10.
Greene C, Worrell S, DeMeester T
Ann Surg
. 2015 Mar;
262(6):910-24.
PMID: 25822684
Objectives: The epidemiologic shift in esophageal cancer from squamous cell carcinoma to esophageal adenocarcinoma coincided with popularization of proton pump inhibitors and has focused attention on gastroesophageal reflux disease as...